EcoDrugPlus

Pim-1 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSCCRG00000075335
Gene Symbol: PIM1
1 Cross references
246 Possible Orthologues:

Pim-1 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSCCRG00000065822
Gene Symbol: PIM1
1 Cross references
247 Possible Orthologues:

Pim-3 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSCCRG00000057568
Gene Symbol: PIM3
1 Cross references
174 Possible Orthologues:

Raf-1 Proto-Oncogene, Serine/threonine Kinase A

Ensembl ID : ENSCCRG00000028114
Gene Symbol: RAF1A
1 Cross references
207 Possible Orthologues:

Raf-1 Proto-Oncogene, Serine/threonine Kinase B

Ensembl ID : ENSCCRG00000029621
Gene Symbol: RAF1B
1 Cross references
153 Possible Orthologues:

Rho-Associated, Coiled-Coil Containing Protein Kinase 1

Ensembl ID : ENSCCRG00000009725
Gene Symbol: ROCK1
1 Cross references
209 Possible Orthologues:

Rho-Associated, Coiled-Coil Containing Protein Kinase 1

Ensembl ID : ENSCCRG00000009200
Gene Symbol: ROCK1
1 Cross references
209 Possible Orthologues:

Sem1 26s Proteasome Subunit

Ensembl ID : ENSCCRG00000035802
Gene Symbol: SEM1
1 Cross references
156 Possible Orthologues:

Udp-Glucose Ceramide Glucosyltransferase

Ensembl ID : ENSCCRG00000065322
Gene Symbol: UGCG
1 Cross references
208 Possible Orthologues:

Udp-Glucose Ceramide Glucosyltransferase

Ensembl ID : ENSCCRG00000009772
Gene Symbol: UGCG
1 Cross references
210 Possible Orthologues:

Wee1 G2 Checkpoint Kinase

Ensembl ID : ENSCCRG00000031167
Gene Symbol: WEE1
1 Cross references
203 Possible Orthologues:

Wee1 G2 Checkpoint Kinase

Ensembl ID : ENSCCRG00000072285
Gene Symbol: WEE1
1 Cross references
203 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).